FDA approves a drug for treating the disease, It is resistant to multiple myeloma
The Food and Drug Administration (FDA) has given Pfizer rapid approval for the use of Elrexfio, which is a subcutaneous treatment for those suffering from resistant multiple myeloma. It is a severe and, until now, incurable form of blood cancer. Elrexfio is a treatment for adults with myeloma who have had a relapse after having […]
Continue Reading